The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Hospital in Changsha
139 Renmin Middle Rd, Furong District, Changsha, Hunan, 410011
About The Second Xiangya Hospital of Central South University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Second Xiangya Hospital of Central South University
28
Central South University
24
Janssen Research & Development, LLC
10
Pfizer
10
Eli Lilly and Company
8
Hoffmann-La Roche
7
Xiamen Amoytop Biotech Co., Ltd.
7
Lifetech Scientific (Shenzhen) Co., Ltd.
6
Peking Union Medical College Hospital
6
BeiGene
5
Boehringer Ingelheim
5
Clinical Trials at The Second Xiangya Hospital of Central South University
During the past decade, The Second Xiangya Hospital of Central South University conducted 213 clinical trials. In the 10-year time frame, 213 clinical trials started and 28 clinical trials were completed, i.e. on
average, 13.1% percent of trials that started reached the finish line to date. In the past 5 years, 104 clinical trials started and 21 clinical trials were completed. i.e. 20.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain
2004-10-01
2006-12-01
Completed
128
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
2005-02-01
2007-12-01
Completed
1,400
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
2009-04-01
2013-05-01
Completed
360
A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing
2009-06-01
2014-04-01
Completed
385
Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients
2009-02-01
2011-12-01
Completed
399
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
2010-04-01
2012-08-01
Terminated
331
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
2010-07-01
2012-03-01
Completed
211
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Second Xiangya Hospital of Central South University" #1 sponsor was "Second Xiangya Hospital of Central South University" with 28 trials, followed by "Central South University" with 24 trials
sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored, "Pfizer" with 10 trials sponsored and "Eli Lilly and Company"
with 10 trials sponsored. Other sponsors include 201 different institutions and
companies that sponsored additional 119 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Xiangya Hospital of Central South University"
#1 collaborator was "Central South University" with 13 trials as a collaborator, "West China Hospital" with 9 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 8 trials as a collaborator, "Wuhan Union Hospital, China" with 7 trials as a collaborator and "Xiangya Hospital of Central South University" with 7 trials as a collaborator. Other collaborators include 527 different institutions and companies that were
collaborators in the rest 393 trials.
Clinical Trials Conditions at The Second Xiangya Hospital of Central South University
According to Clinical.Site data, the most researched conditions in "The Second Xiangya Hospital of Central South University" are
"Schizophrenia" (14 trials), "Chronic Hepatitis B" (9 trials), "Type 1 Diabetes Mellitus" (6 trials), "Non-small Cell Lung Cancer" (5 trials) and "Atopic Dermatitis" (4 trials). Many other conditions were trialed in "The Second Xiangya Hospital of Central South University" in a lesser frequency.
Clinical Trials Intervention Types at The Second Xiangya Hospital of Central South University
Most popular intervention types in "The Second Xiangya Hospital of Central South University" are "Drug" (198 trials), "Other" (28 trials), "Procedure" (22 trials), "Device" (20 trials) and "Biological" (18 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (55 trials), "placebo" (9 trials), "Insulin" (5 trials), "Ypeginterferon alfa-2b" (5 trials) and "Guselkumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at The Second Xiangya Hospital of Central South University
The vast majority of trials in "The Second Xiangya Hospital of Central South University" are
276 trials for "All" genders and 10 trials for "Female" genders.
Clinical Trials Status at The Second Xiangya Hospital of Central South University
Currently, there are 106 active trials in "The Second Xiangya Hospital of Central South University".
8 are not yet recruiting,
76 are recruiting,
20 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 105 completed trials in The Second Xiangya Hospital of Central South University,
3 suspended trials,
and 13 terminated clinical trials to date.
Out of the total trials that were conducted in The Second Xiangya Hospital of Central South University, 14 "Phase 1"
clinical trials were conducted, 68 "Phase 2" clinical
trials and 101 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 36 trials, and there were
also 47 trials that are defined as “Not Applicable".